Evercore ISI keeps DR Horton at In-Line and cuts price target to $152
Evercore ISI maintained its In-Line rating on DR Horton and lowered its price target to $152 a share from $166, Dow Jones Newswires reports, citing Benzinga.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Analysts at Evercore ISI kept their In-Line rating on DR Horton but reduced the company's price target to $152 per share from $166. Dow Jones Newswires reports the change, citing Benzinga.
The update covers only the analysts' revised valuation. It does not include any financial results from the company.
why it matters
A lower price target combined with an unchanged neutral rating means the bank has adjusted its expected value for the shares without changing its overall view of the stock. For investors, such revisions matter mainly as a gauge for the homebuilding sector rather than as a standalone signal for the share price.
tags
instruments
sources
- DR Horton Is Maintained at In-Line by Evercore ISI Group — Dow Jones Newswires, 30 October 2026 at 12:41 UTC
- Kimco Realty Is Maintained at In-Line by Evercore ISI Group — Dow Jones Newswires, 30 October 2026 at 12:48 UTC
- Incyte Is Maintained at In-Line by Evercore ISI Group — Dow Jones Newswires, 30 October 2026 at 12:47 UTC
- Sirius XM Is Maintained at In-Line by Evercore ISI Group — Dow Jones Newswires, 30 October 2026 at 12:54 UTC
- Pinterest Is Maintained at In-Line by Evercore ISI Group — Dow Jones Newswires, 30 October 2026 at 12:52 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗